References
- US Food and Drug Administration. Guidance for industry. Estrogen and estrogen/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms – recommendations for clinical evaluation. January 2003. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM071643.pdf [Last accessed 14 June 2013]
- Levine KB, Williams RE, Hartmann KE. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause 2008;15(4 Pt 1):661-6
- Genazzani AR, Schneider HP, Panay N, et al. The European Menopause Survey 2005: women’s perceptions on the menopause and postmenopausal hormone therapy. Gynecol Endocrinol 2006;22:369-75
- Nappi RE, Kokot-Kierepa M. Women’s voices in the menopause: results from an international survey on vaginal atrophy. Maturitas 2010;67:233-8
- Kingsberg SA, Wysocki S, Magnus L, et al. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (Real Women’s Views of Treatment Options for Menopausal Vaginal ChangEs) Survey. J Sex Med 2013;10:1790-9
- Lester J, Bernhard L, Ryan-Wenger N. A self-report instrument that describes urogenital atrophy symptoms in breast cancer survivors. West J Nurs Res 2012;34:72-96
- Macbride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc 2010;85:87-94
- Sturdee DW, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010;13:509-22
- Goldstein I. Recognizing and treating urogenital atrophy in postmenopausal women. J Womens Health (Larchmt) 2010;19:425-32
- Van Voorhis BJ. Genitourinary symptoms in the menopausal transition. Am J Med 2005;118(12B):47-53S
- Jackson SL, Scholes D, Boyko EJ, et al. Predictors of urinary incontinence in a prospective cohort of postmenopausal women. Obstet Gynecol 2006;108:855-62
- American College of Obstetricians and Gynecologists. Genitourinary tract changes. Obstet Gynecol 2004;104(4 Suppl):56-61S
- Frank SM, Ziegler C, Kokot-Kierepa M, et al. Vaginal Health: Insights, Views & Attitudes (VIVA) survey – Canadian cohort. Menopause Int 2013;19:20-7
- Nappi RE, Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes (VIVA) – results from an international survey. Climacteric 2012;15:36-44
- Simon JA, Kokot-Kierepa M, Goldstein J, et al. Vaginal health in the United States: results from the Vaginal Health: Insights, Views & Attitudes survey. Menopause 2013;20:1043-8
- Nappi RE, Davis SR. The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI. Climacteric 2012;15:267-74
- Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 2003;49:53-70
- Chahal HS, Drake WM. The endocrine system and ageing. J Pathol 2007;211:173-80